Clinical advantages of immunotherapy are seen in brain cancer metastases.

Published Date: 07 Jun 2023

Immune checkpoint inhibitor pembrolizumab was the subject of a phase 2 clinical trial where researchers discovered that it helped 42% of patients with metastatic brain cancer, with seven of the trial's participants surviving.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

2.

The main subject is associated with suicide in the United States.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Firefighters who eat better can combat cancer.

5.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot